The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Sexually Transmitted Disease (STD) Diagnosis Market Research Report 2024

Global Sexually Transmitted Disease (STD) Diagnosis Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1893138

No of Pages : 92

Ask Your Query
Synopsis
The global Sexually Transmitted Disease (STD) Diagnosis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Sexually Transmitted Disease (STD) Diagnosis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Sexually Transmitted Disease (STD) Diagnosis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Sexually Transmitted Disease (STD) Diagnosis in Government organizations is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Sexually Transmitted Disease (STD) Diagnosis include Abbott, Roche, Thermo Fisher Scientific, Aposcience, BCR Diagnostics, BD Medical, Biocartis, BioMerieux and Bio-Rad, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Sexually Transmitted Disease (STD) Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sexually Transmitted Disease (STD) Diagnosis.
Report Scope
The Sexually Transmitted Disease (STD) Diagnosis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sexually Transmitted Disease (STD) Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sexually Transmitted Disease (STD) Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Roche
Thermo Fisher Scientific
Aposcience
BCR Diagnostics
BD Medical
Biocartis
BioMerieux
Bio-Rad
Cepheid
Danaher
DiaSorin
Quidel
GenMark Diagnostics
Hologic
OraSure Technologies
Qualigen
Segment by Type
Chlamydia testing
Syphilis testing
Gonorrhoea testing
Herpes simplex virus testing
Human papilloma virus testing
Human immunodeficiency virus testing
Segment by Application
Government organizations
Hospitals
Diagnostic clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sexually Transmitted Disease (STD) Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Chlamydia testing
1.2.3 Syphilis testing
1.2.4 Gonorrhoea testing
1.2.5 Herpes simplex virus testing
1.2.6 Human papilloma virus testing
1.2.7 Human immunodeficiency virus testing
1.3 Market by Application
1.3.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Government organizations
1.3.3 Hospitals
1.3.4 Diagnostic clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Perspective (2019-2030)
2.2 Sexually Transmitted Disease (STD) Diagnosis Growth Trends by Region
2.2.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sexually Transmitted Disease (STD) Diagnosis Historic Market Size by Region (2019-2024)
2.2.3 Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Region (2025-2030)
2.3 Sexually Transmitted Disease (STD) Diagnosis Market Dynamics
2.3.1 Sexually Transmitted Disease (STD) Diagnosis Industry Trends
2.3.2 Sexually Transmitted Disease (STD) Diagnosis Market Drivers
2.3.3 Sexually Transmitted Disease (STD) Diagnosis Market Challenges
2.3.4 Sexually Transmitted Disease (STD) Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sexually Transmitted Disease (STD) Diagnosis Players by Revenue
3.1.1 Global Top Sexually Transmitted Disease (STD) Diagnosis Players by Revenue (2019-2024)
3.1.2 Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Players (2019-2024)
3.2 Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sexually Transmitted Disease (STD) Diagnosis Revenue
3.4 Global Sexually Transmitted Disease (STD) Diagnosis Market Concentration Ratio
3.4.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Disease (STD) Diagnosis Revenue in 2023
3.5 Sexually Transmitted Disease (STD) Diagnosis Key Players Head office and Area Served
3.6 Key Players Sexually Transmitted Disease (STD) Diagnosis Product Solution and Service
3.7 Date of Enter into Sexually Transmitted Disease (STD) Diagnosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sexually Transmitted Disease (STD) Diagnosis Breakdown Data by Type
4.1 Global Sexually Transmitted Disease (STD) Diagnosis Historic Market Size by Type (2019-2024)
4.2 Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Type (2025-2030)
5 Sexually Transmitted Disease (STD) Diagnosis Breakdown Data by Application
5.1 Global Sexually Transmitted Disease (STD) Diagnosis Historic Market Size by Application (2019-2024)
5.2 Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Sexually Transmitted Disease (STD) Diagnosis Market Size (2019-2030)
6.2 North America Sexually Transmitted Disease (STD) Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2019-2024)
6.4 North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size (2019-2030)
7.2 Europe Sexually Transmitted Disease (STD) Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2019-2024)
7.4 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size (2019-2030)
8.2 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (2019-2024)
8.4 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size (2019-2030)
9.2 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2019-2024)
9.4 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size (2019-2030)
10.2 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2019-2024)
10.4 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Sexually Transmitted Disease (STD) Diagnosis Introduction
11.1.4 Abbott Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Sexually Transmitted Disease (STD) Diagnosis Introduction
11.2.4 Roche Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2019-2024)
11.2.5 Roche Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Introduction
11.3.4 Thermo Fisher Scientific Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2019-2024)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Aposcience
11.4.1 Aposcience Company Detail
11.4.2 Aposcience Business Overview
11.4.3 Aposcience Sexually Transmitted Disease (STD) Diagnosis Introduction
11.4.4 Aposcience Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2019-2024)
11.4.5 Aposcience Recent Development
11.5 BCR Diagnostics
11.5.1 BCR Diagnostics Company Detail
11.5.2 BCR Diagnostics Business Overview
11.5.3 BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Introduction
11.5.4 BCR Diagnostics Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2019-2024)
11.5.5 BCR Diagnostics Recent Development
11.6 BD Medical
11.6.1 BD Medical Company Detail
11.6.2 BD Medical Business Overview
11.6.3 BD Medical Sexually Transmitted Disease (STD) Diagnosis Introduction
11.6.4 BD Medical Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2019-2024)
11.6.5 BD Medical Recent Development
11.7 Biocartis
11.7.1 Biocartis Company Detail
11.7.2 Biocartis Business Overview
11.7.3 Biocartis Sexually Transmitted Disease (STD) Diagnosis Introduction
11.7.4 Biocartis Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2019-2024)
11.7.5 Biocartis Recent Development
11.8 BioMerieux
11.8.1 BioMerieux Company Detail
11.8.2 BioMerieux Business Overview
11.8.3 BioMerieux Sexually Transmitted Disease (STD) Diagnosis Introduction
11.8.4 BioMerieux Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2019-2024)
11.8.5 BioMerieux Recent Development
11.9 Bio-Rad
11.9.1 Bio-Rad Company Detail
11.9.2 Bio-Rad Business Overview
11.9.3 Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Introduction
11.9.4 Bio-Rad Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2019-2024)
11.9.5 Bio-Rad Recent Development
11.10 Cepheid
11.10.1 Cepheid Company Detail
11.10.2 Cepheid Business Overview
11.10.3 Cepheid Sexually Transmitted Disease (STD) Diagnosis Introduction
11.10.4 Cepheid Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2019-2024)
11.10.5 Cepheid Recent Development
11.11 Danaher
11.11.1 Danaher Company Detail
11.11.2 Danaher Business Overview
11.11.3 Danaher Sexually Transmitted Disease (STD) Diagnosis Introduction
11.11.4 Danaher Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2019-2024)
11.11.5 Danaher Recent Development
11.12 DiaSorin
11.12.1 DiaSorin Company Detail
11.12.2 DiaSorin Business Overview
11.12.3 DiaSorin Sexually Transmitted Disease (STD) Diagnosis Introduction
11.12.4 DiaSorin Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2019-2024)
11.12.5 DiaSorin Recent Development
11.13 Quidel
11.13.1 Quidel Company Detail
11.13.2 Quidel Business Overview
11.13.3 Quidel Sexually Transmitted Disease (STD) Diagnosis Introduction
11.13.4 Quidel Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2019-2024)
11.13.5 Quidel Recent Development
11.14 GenMark Diagnostics
11.14.1 GenMark Diagnostics Company Detail
11.14.2 GenMark Diagnostics Business Overview
11.14.3 GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Introduction
11.14.4 GenMark Diagnostics Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2019-2024)
11.14.5 GenMark Diagnostics Recent Development
11.15 Hologic
11.15.1 Hologic Company Detail
11.15.2 Hologic Business Overview
11.15.3 Hologic Sexually Transmitted Disease (STD) Diagnosis Introduction
11.15.4 Hologic Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2019-2024)
11.15.5 Hologic Recent Development
11.16 OraSure Technologies
11.16.1 OraSure Technologies Company Detail
11.16.2 OraSure Technologies Business Overview
11.16.3 OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Introduction
11.16.4 OraSure Technologies Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2019-2024)
11.16.5 OraSure Technologies Recent Development
11.17 Qualigen
11.17.1 Qualigen Company Detail
11.17.2 Qualigen Business Overview
11.17.3 Qualigen Sexually Transmitted Disease (STD) Diagnosis Introduction
11.17.4 Qualigen Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2019-2024)
11.17.5 Qualigen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock